Learning Hub Central
Immunotherapy
Immunotherapy in Gynecologic Malignancies
Immunotherapy
Non-CME Credit Course
2021 NOSCM | Toxicities in Immunotherapy
Immunotherapy
Non-CME Credit Course
Immunotherapy in Kidney & Bladder Cancer
Immunotherapy
Non-CME Credit Course
2022 CCC | Advances in Car-T Cells and Other Cellular Based Therapies
Immunotherapy
Non-CME Credit Course
2022 CCC | The Future of Biomarkers of Immunotherapy in Cancer
Immunotherapy
Non-CME Credit Course
2022 NOSCM | Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?
Immunotherapy
Non-CME Credit Course
2022 NOSCM | Immunotherapy, Targeted Therapy & And What After in Melanoma?
Immunotherapy
Non-CME Credit Course
2022 NOSCM | Immunotherapy in Head & Neck Cancer and What After IO Failure?
Immunotherapy
Non-CME Credit Course
2022 MLS Nashville | Keynote Lecture: CAR-T Cell and Cellular Therapy Update
Immunotherapy
Non-CME Credit Course
2023 CCC | Advances in Non-PD(L)1 Immunotherapies
Immunotherapy
Non-CME Credit Course
2022 MCM | Immunotherapy for Melanoma
Immunotherapy
Non-CME Credit Course
Immunotherapy in Kidney & Bladder Tumors
Immunotherapy
Non-CME Credit Course
2021 NOSCM | Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Immunotherapy
Non-CME Credit Course
2021 MCM | Immunotherapy Session
Immunotherapy
Non-CME Credit Course
Progress in CAR-T Cell Therapies
Immunotherapy
Non-CME Credit Course
Challenges in Breast Cancer Immunotherapy
Immunotherapy
Non-CME Credit Course
Immunotherapy for Kidney and Bladder Malignancies
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy and BiTe Treatment Updates in Prostate Cancer
Immunotherapy
Non-CME Credit Course
2024 NOSCM | Melanoma: Novel Advances in Immunotherapy
Immunotherapy
Non-CME Credit Course
2024 NOSCM | Cervical and Uterine Cancer: Novel Advances in Personalized Medicine in 2024
Immunotherapy
Non-CME Credit Course
2024 NOSCM | Squamous Cell Carcinoma of Head and Neck: Where Are We in 2024?
Immunotherapy
Non-CME Credit Course
2024 MCM | New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?
Immunotherapy
Non-CME Credit Course
2024 MCM | What To Do When Patients Getting Immunotherapy Do Not Respond to Steroids (Hepatitis, Colitis, Pneumonitis, and Others)
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy Updates in Melanoma
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy Updates in Breast Cancer
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy and HER2 Targeted Updates in Esophageal Cancer
Immunotherapy
Non-CME Credit Course
2024 NOSCM | Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy and ADC Updates in Urothelial Cancers
Immunotherapy
Non-CME Credit Course
2024 MLS Cleveland | Immunotherapy Updates in Head and Neck Cancer
Immunotherapy
Non-CME Credit Course
2022 AIO | Updates in CAR T Therapies
Immunotherapy
Non-CME Credit Course
2024 SPECTRUM | Combined Angio-CT system – Precision therapy in IO
Immunotherapy
Non-CME Credit Course
2024 SPECTRUM | Precision Imaging in IO
Immunotherapy
Non-CME Credit Course
2021 CCC | Management of Immune Related Adverse Events
Immunotherapy
Non-CME Credit Course
2023 CCC | Advances in Car-T Cells Development for Cancer Therapy
Immunotherapy
Non-CME Credit Course
Contact Us
